|
USRE30985E
(en)
|
1978-01-01 |
1982-06-29 |
|
Serum-free cell culture media
|
|
US5179017A
(en)
|
1980-02-25 |
1993-01-12 |
The Trustees Of Columbia University In The City Of New York |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
|
US4399216A
(en)
|
1980-02-25 |
1983-08-16 |
The Trustees Of Columbia University |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
|
US4510245A
(en)
|
1982-11-18 |
1985-04-09 |
Chiron Corporation |
Adenovirus promoter system
|
|
US4560655A
(en)
|
1982-12-16 |
1985-12-24 |
Immunex Corporation |
Serum-free cell culture medium and process for making same
|
|
US4657866A
(en)
|
1982-12-21 |
1987-04-14 |
Sudhir Kumar |
Serum-free, synthetic, completely chemically defined tissue culture media
|
|
JPS59156299A
(ja)
|
1983-02-28 |
1984-09-05 |
Noda Sangyo Kagaku Kenkyusho |
Ｎ−アセチルヘキソサミンの定量法及びその定量用試薬
|
|
GB8308235D0
(en)
|
1983-03-25 |
1983-05-05 |
Celltech Ltd |
Polypeptides
|
|
US4534972A
(en)
|
1983-03-29 |
1985-08-13 |
Miles Laboratories, Inc. |
Protein compositions substantially free from infectious agents
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
DD266710A3
(de)
|
1983-06-06 |
1989-04-12 |
Ve Forschungszentrum Biotechnologie |
Verfahren zur biotechnischen Herstellung van alkalischer Phosphatase
|
|
US4767704A
(en)
|
1983-10-07 |
1988-08-30 |
Columbia University In The City Of New York |
Protein-free culture medium
|
|
EP0154316B1
(en)
|
1984-03-06 |
1989-09-13 |
Takeda Chemical Industries, Ltd. |
Chemically modified lymphokine and production thereof
|
|
US4879231A
(en)
|
1984-10-30 |
1989-11-07 |
Phillips Petroleum Company |
Transformation of yeasts of the genus pichia
|
|
US5168062A
(en)
|
1985-01-30 |
1992-12-01 |
University Of Iowa Research Foundation |
Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
|
|
GB8516415D0
(en)
|
1985-06-28 |
1985-07-31 |
Celltech Ltd |
Culture of animal cells
|
|
US4968615A
(en)
|
1985-12-18 |
1990-11-06 |
Ciba-Geigy Corporation |
Deoxyribonucleic acid segment from a virus
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
US4927762A
(en)
|
1986-04-01 |
1990-05-22 |
Cell Enterprises, Inc. |
Cell culture medium with antioxidant
|
|
GB8610600D0
(en)
|
1986-04-30 |
1986-06-04 |
Novo Industri As |
Transformation of trichoderma
|
|
US5045468A
(en)
*
|
1986-12-12 |
1991-09-03 |
Cell Enterprises, Inc. |
Protein-free culture medium which promotes hybridoma growth
|
|
US5476996A
(en)
|
1988-06-14 |
1995-12-19 |
Lidak Pharmaceuticals |
Human immune system in non-human animal
|
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
US6048728A
(en)
*
|
1988-09-23 |
2000-04-11 |
Chiron Corporation |
Cell culture medium for enhanced cell growth, culture longevity, and product expression
|
|
AU632065B2
(en)
|
1988-09-23 |
1992-12-17 |
Novartis Vaccines And Diagnostics, Inc. |
Cell culture medium for enhanced cell growth, culture longevity and product expression
|
|
JP2989002B2
(ja)
|
1988-12-22 |
1999-12-13 |
キリン―アムジエン・インコーポレーテツド |
化学修飾顆粒球コロニー刺激因子
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
EP0402226A1
(en)
|
1989-06-06 |
1990-12-12 |
Institut National De La Recherche Agronomique |
Transformation vectors for yeast yarrowia
|
|
US5427908A
(en)
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
|
US5110913A
(en)
*
|
1990-05-25 |
1992-05-05 |
Miles Inc. |
Antibody purification method
|
|
US5096816A
(en)
*
|
1990-06-05 |
1992-03-17 |
Cetus Corporation |
In vitro management of ammonia's effect on glycosylation of cell products through pH control
|
|
WO1992020791A1
(en)
|
1990-07-10 |
1992-11-26 |
Cambridge Antibody Technology Limited |
Methods for producing members of specific binding pairs
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
US5122469A
(en)
|
1990-10-03 |
1992-06-16 |
Genentech, Inc. |
Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
|
|
EP0564531B1
(en)
|
1990-12-03 |
1998-03-25 |
Genentech, Inc. |
Enrichment method for variant proteins with altered binding properties
|
|
ATE363532T1
(de)
|
1991-03-01 |
2007-06-15 |
Dyax Corp |
Verfahren zur herstellung bindender miniproteine
|
|
DK1471142T3
(da)
|
1991-04-10 |
2009-03-09 |
Scripps Research Inst |
Heterodimere receptor-biblioteker under anvendelse af fagemider
|
|
DE4122599C2
(de)
|
1991-07-08 |
1993-11-11 |
Deutsches Krebsforsch |
Phagemid zum Screenen von Antikörpern
|
|
EP0666312A1
(en)
*
|
1994-02-08 |
1995-08-09 |
Wolfgang A. Renner |
Process for the improvement of mammalian cell growth
|
|
US5429746A
(en)
|
1994-02-22 |
1995-07-04 |
Smith Kline Beecham Corporation |
Antibody purification
|
|
US5853714A
(en)
*
|
1995-03-27 |
1998-12-29 |
Genetics Institute, Inc. |
Method for purification of IL-12
|
|
US5641870A
(en)
*
|
1995-04-20 |
1997-06-24 |
Genentech, Inc. |
Low pH hydrophobic interaction chromatography for antibody purification
|
|
US6656466B1
(en)
*
|
1995-06-06 |
2003-12-02 |
Genetech, Inc. |
Human tumor necrosis factor—immunoglobulin(TNFR1-IgG1) chimera composition
|
|
US5705364A
(en)
*
|
1995-06-06 |
1998-01-06 |
Genentech, Inc. |
Mammalian cell culture process
|
|
US5721121A
(en)
*
|
1995-06-06 |
1998-02-24 |
Genentech, Inc. |
Mammalian cell culture process for producing a tumor necrosis factor receptor immunoglobulin chimeric protein
|
|
JP4306813B2
(ja)
*
|
1995-09-19 |
2009-08-05 |
アスビオファーマ株式会社 |
動物細胞の新規培養方法
|
|
EP0802257B1
(fr)
*
|
1996-04-19 |
2002-08-21 |
Societe Des Produits Nestle S.A. |
Lignée immortalisée de cellules épithéliales du colon humain
|
|
WO1998017786A1
(en)
|
1996-10-23 |
1998-04-30 |
Oravax, Inc. |
Heat inactivation of viruses in antibody preparations
|
|
ATE256476T1
(de)
*
|
1996-11-15 |
2004-01-15 |
Kennedy Inst Of Rheumatology |
Unterdrückung von tnfalpha und il-12 in der therapie
|
|
ES2335365T3
(es)
*
|
1996-11-27 |
2010-03-25 |
Genentech, Inc. |
Purificacion por afinidad de polipeptido en una matriz de proteina a.
|
|
US6955917B2
(en)
*
|
1997-06-20 |
2005-10-18 |
Bayer Healthcare Llc |
Chromatographic method for high yield purification and viral inactivation of antibodies
|
|
IL121900A
(en)
|
1997-10-07 |
2001-12-23 |
Omrix Biopharmaceuticals Ltd |
A method for the purification of immunoglobulins
|
|
US20020045207A1
(en)
*
|
1997-10-31 |
2002-04-18 |
Lynne A. Krummen |
Glycoprotein production process
|
|
AU1663599A
(en)
|
1997-12-19 |
1999-07-12 |
Novo Nordisk A/S |
Method for producing heterologous proteins in eukaryotic cells on an industrial scale using nucleotide-manipulating agents
|
|
AU760048B2
(en)
*
|
1998-05-06 |
2003-05-08 |
Genentech Inc. |
Protein purification by ion exchange chromatography
|
|
US6528286B1
(en)
*
|
1998-05-29 |
2003-03-04 |
Genentech, Inc. |
Mammalian cell culture process for producing glycoproteins
|
|
US6914128B1
(en)
|
1999-03-25 |
2005-07-05 |
Abbott Gmbh & Co. Kg |
Human antibodies that bind human IL-12 and methods for producing
|
|
DE60044690D1
(de)
*
|
1999-09-27 |
2010-08-26 |
Genentech Inc |
Verfahren zur Herstellung von rekombinanten Proteinen mittels Inhibitoren von Apoptose
|
|
ES2266159T3
(es)
*
|
2000-02-08 |
2007-03-01 |
Genentech, Inc. |
Mejora de la galactosilacion de glicoproteinas recombinantes.
|
|
EP1257585A2
(en)
|
2000-02-10 |
2002-11-20 |
Basf Aktiengesellschaft |
Antibodies that bind human interleukin-18 and methods of making and using
|
|
US7598055B2
(en)
|
2000-06-28 |
2009-10-06 |
Glycofi, Inc. |
N-acetylglucosaminyltransferase III expression in lower eukaryotes
|
|
EP1175931A1
(en)
*
|
2000-07-25 |
2002-01-30 |
Computer Cell Culture Center S.A. |
Integration of high cell density bioreactor operation with ultra fast on-line downstream processing
|
|
US6635448B2
(en)
*
|
2000-08-21 |
2003-10-21 |
Clonexdevelopment, Inc. |
Methods and compositions for increasing protein yield from a cell culture
|
|
US6693173B2
(en)
*
|
2000-12-26 |
2004-02-17 |
Alpha Therapeutic Corporation |
Method to remove citrate and aluminum from proteins
|
|
US20030096414A1
(en)
*
|
2001-03-27 |
2003-05-22 |
Invitrogen Corporation |
Culture medium for cell growth and transfection
|
|
CN100448992C
(zh)
|
2001-05-11 |
2009-01-07 |
麒麟医药株式会社 |
含人抗体λ轻链基因的人类人工染色体
|
|
ES2266535T3
(es)
*
|
2001-06-05 |
2007-03-01 |
Genetics Institute, Llc |
Procedimientos relativos a la purificacion de proteinas altamente anionicas.
|
|
KR20100018071A
(ko)
*
|
2001-08-03 |
2010-02-16 |
글리카트 바이오테크놀로지 아게 |
항체 의존적 세포 독성이 증가된 항체 글리코실화 변이체
|
|
HUP0402158A2
(hu)
*
|
2001-10-02 |
2005-01-28 |
Novo Nordisk Health Care Ag |
Rekombináns fehérjék előállítási eljárása eukarióta sejtekben
|
|
MXPA04003798A
(es)
*
|
2001-10-25 |
2004-07-30 |
Genentech Inc |
Composiciones de glicoproteina.
|
|
MXPA04005190A
(es)
|
2001-11-28 |
2005-02-17 |
Sandoz Ag |
Proceso para cultivo de celulas.
|
|
JP4363986B2
(ja)
*
|
2001-12-21 |
2009-11-11 |
イミュネックス・コーポレーション |
タンパク質の精製方法
|
|
US20030201229A1
(en)
*
|
2002-02-04 |
2003-10-30 |
Martin Siwak |
Process for prefiltration of a protein solution
|
|
AU2003210802B2
(en)
*
|
2002-02-05 |
2009-09-10 |
Genentech Inc. |
Protein purification
|
|
CA2417689C
(en)
*
|
2002-03-05 |
2006-05-09 |
F. Hoffmann-La Roche Ag |
Improved methods for growing mammalian cells in vitro
|
|
US20030190710A1
(en)
*
|
2002-03-28 |
2003-10-09 |
Devries Ruth L. |
Control of glycoforms in IgG
|
|
JPWO2003085118A1
(ja)
*
|
2002-04-09 |
2005-08-11 |
協和醗酵工業株式会社 |
抗体組成物の製造方法
|
|
RU2304587C2
(ru)
*
|
2002-06-10 |
2007-08-20 |
Гуд Байотек Копэрейшн |
СПОСОБ СЕЛЕКТИВНОГО ВЫДЕЛЕНИЯ АНТИТЕЛ IgY ИЗ ЯИЧНОГО ЖЕЛТКА ПТИЦ ОТРЯДА ГУСЕОБРАЗНЫХ (ВАРИАНТЫ)
|
|
JP4510938B2
(ja)
*
|
2002-07-15 |
2010-07-28 |
イミュネックス・コーポレーション |
哺乳動物細胞により産生されるタンパク質のシアル酸付加を調節する方法および培地
|
|
KR20130001318A
(ko)
*
|
2002-07-19 |
2013-01-03 |
애보트 바이오테크놀로지 리미티드 |
ＴＮＦα 관련 질환의 치료
|
|
US7067279B1
(en)
*
|
2002-08-23 |
2006-06-27 |
Immunex Corporation |
Cell culture performance with betaine
|
|
US6974681B1
(en)
*
|
2002-08-23 |
2005-12-13 |
Immunex Corporation |
Cell culture performance with vanadate
|
|
CN1856324A
(zh)
*
|
2002-09-17 |
2006-11-01 |
Gtc生物治疗学公司 |
缺乏重链间二硫键的免疫球蛋白分子的分离
|
|
US7208585B2
(en)
*
|
2002-09-18 |
2007-04-24 |
Genencor International, Inc. |
Protein purification
|
|
US20040162414A1
(en)
|
2002-11-22 |
2004-08-19 |
Santora Ling C. |
Method for reducing or preventing modification of a polypeptide in solution
|
|
WO2004058944A2
(en)
*
|
2002-12-23 |
2004-07-15 |
Bristol-Myers Squibb Company |
Product quality enhancement in mammalian cell culture processes for protein production
|
|
PL377731A1
(pl)
*
|
2002-12-23 |
2006-02-06 |
Bristol-Myers Squibb Company |
Sposoby hodowli komórek ssaczych do wytwarzania białka
|
|
ES2344789T5
(es)
*
|
2003-05-15 |
2017-06-14 |
Wyeth Llc |
Alimentación restringida de glucosa para el cultivo de células animales
|
|
HUE029951T2
(en)
*
|
2003-07-28 |
2017-04-28 |
Genentech Inc |
Reduction of Protein A Dissolution in Protein A Affinity Chromatography
|
|
GB2404665B
(en)
*
|
2003-08-08 |
2005-07-06 |
Cambridge Antibody Tech |
Cell culture
|
|
EP1673452B1
(en)
*
|
2003-10-10 |
2015-12-23 |
Novo Nordisk Health Care AG |
Method for large-scale production of a polypeptide in eukaryote cells
|
|
CN102276717B
(zh)
*
|
2003-10-27 |
2015-09-09 |
惠氏公司 |
使用羟磷灰石层析除去高分子量聚集体
|
|
US8084032B2
(en)
|
2004-01-21 |
2011-12-27 |
Ajinomoto Co., Inc. |
Purification method which prevents denaturation of an antibody
|
|
SE0400886D0
(sv)
*
|
2004-04-02 |
2004-04-02 |
Amersham Biosciences Ab |
Process of purification
|
|
US20060127950A1
(en)
*
|
2004-04-15 |
2006-06-15 |
Massachusetts Institute Of Technology |
Methods and products related to the improved analysis of carbohydrates
|
|
KR20070008645A
(ko)
|
2004-05-04 |
2007-01-17 |
노보 노르디스크 헬스 케어 악티엔게젤샤프트 |
폴리펩티드의 ｏ-연결된 단백당형 및 그들의 제조 방법
|
|
TWI384069B
(zh)
|
2004-08-27 |
2013-02-01 |
Pfizer Ireland Pharmaceuticals |
多胜肽之製法
|
|
NZ588616A
(en)
*
|
2004-09-30 |
2012-05-25 |
Bayer Healthcare Llc |
An apparatus for separating a protein of interest comprising a purification system integrated with a particle removal system
|
|
US20060094104A1
(en)
|
2004-10-29 |
2006-05-04 |
Leopold Grillberger |
Animal protein-free media for cultivation of cells
|
|
JP2006143601A
(ja)
*
|
2004-11-16 |
2006-06-08 |
Yamato Yakuhin Kk |
血液粘度低下剤
|
|
US8728828B2
(en)
*
|
2004-12-22 |
2014-05-20 |
Ge Healthcare Bio-Sciences Ab |
Purification of immunoglobulins
|
|
US8530192B2
(en)
|
2005-02-11 |
2013-09-10 |
Novo Nordisk Healthcare Ag |
Production of a polypeptide in a serum-free cell culture liquid containing plant protein hydrolysate
|
|
WO2006099308A2
(en)
*
|
2005-03-11 |
2006-09-21 |
Wyeth |
A method of weak partitioning chromatography
|
|
CN101218247A
(zh)
|
2005-04-11 |
2008-07-09 |
米德列斯公司 |
利用hcic和离子交换层析的蛋白质纯化
|
|
WO2006113743A2
(en)
*
|
2005-04-18 |
2006-10-26 |
Massachusetts Institute Of Technology |
Compositions and methods for rna interference with sialidase expression and uses thereof
|
|
US7247457B2
(en)
*
|
2005-04-26 |
2007-07-24 |
United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention |
Detection and identification of enteroviruses by semi-nested amplification of the enterovirus VP1 protein
|
|
US20090208500A1
(en)
*
|
2005-06-03 |
2009-08-20 |
Genentech, Inc. |
Method of producing antibodies with improved function
|
|
EP3673919A1
(en)
*
|
2005-06-14 |
2020-07-01 |
Amgen Inc. |
Self-buffering protein formulations
|
|
TW200740839A
(en)
*
|
2005-06-17 |
2007-11-01 |
Wyeth Corp |
Methods of purifying Fc region containing proteins
|
|
LT1917276T
(lt)
*
|
2005-08-26 |
2018-05-25 |
Ares Trading S.A. |
Glikozilinto interferono beta gavimo būdas
|
|
PE20070796A1
(es)
*
|
2005-10-24 |
2007-08-15 |
Wyeth Corp |
Metodo de produccion proteica utilizando compuestos anti-senescencia
|
|
US7972810B2
(en)
*
|
2005-12-08 |
2011-07-05 |
Amgen Inc. |
Production of glycoproteins using manganese
|
|
US20070190057A1
(en)
|
2006-01-23 |
2007-08-16 |
Jian Wu |
Methods for modulating mannose content of recombinant proteins
|
|
NZ611859A
(en)
*
|
2006-04-05 |
2014-12-24 |
Abbvie Biotechnology Ltd |
Antibody purification
|
|
JP5406710B2
(ja)
*
|
2006-05-19 |
2014-02-05 |
グライコフィ， インコーポレイテッド |
エリスロポエチン組成物
|
|
WO2009017491A1
(en)
*
|
2006-06-14 |
2009-02-05 |
Smithkline Beecham Corporation |
Methods for purifying antibodies using ceramic hydroxyapatite
|
|
WO2008007280A2
(en)
|
2006-06-28 |
2008-01-17 |
Koninklijke Philips Electronics N.V. |
Assay system and method
|
|
CA2657248C
(en)
|
2006-07-13 |
2018-10-30 |
Wyeth |
Production of glycoproteins
|
|
MX2009002014A
(es)
*
|
2006-08-28 |
2009-03-09 |
Ares Trading Sa |
Proceso para la purificacion de proteinas que contienen fc.
|
|
CL2007002615A1
(es)
*
|
2006-09-08 |
2008-04-18 |
Wyeth Corp |
Metodos para aislar o purificar un producto que comprende poner el producto enlazado en contacto con al menos una solucion de lavado que comprende arginina y luego eluir el producto; y dicho producto.
|
|
SG174804A1
(enExample)
*
|
2006-09-13 |
2011-10-28 |
Abbott Lab |
|
|
US8911964B2
(en)
*
|
2006-09-13 |
2014-12-16 |
Abbvie Inc. |
Fed-batch method of making human anti-TNF-alpha antibody
|
|
US10982250B2
(en)
*
|
2006-09-18 |
2021-04-20 |
Genentech, Inc. |
Methods of protein production
|
|
US20080132688A1
(en)
|
2006-09-22 |
2008-06-05 |
Amgen Inc. |
Methods for Removing Viral Contaminants During Protein Purification
|
|
MX2009004519A
(es)
*
|
2006-11-03 |
2009-05-12 |
Wyeth Corp |
Sustancias que inhiben la glucolisis en un cultivo de celulas.
|
|
EP2089424B1
(en)
|
2006-12-06 |
2015-07-01 |
JCR PHARMACEUTICALS Co., LTD. |
Method for production of human erythropoietin
|
|
WO2008079280A1
(en)
*
|
2006-12-21 |
2008-07-03 |
Millipore Corporation |
Purification of proteins
|
|
CN101679941A
(zh)
*
|
2007-03-02 |
2010-03-24 |
惠氏公司 |
在细胞培养物中使用铜和谷氨酸盐生产多肽
|
|
JP5466635B2
(ja)
*
|
2007-03-30 |
2014-04-09 |
メディミューン，エルエルシー |
脱アミド化プロフィールが低減した抗体
|
|
CN101652379B
(zh)
*
|
2007-03-30 |
2014-05-14 |
Abbvie公司 |
用于增加宿主细胞中重组蛋白表达的重组表达载体元件(reves)
|
|
EP2508613A3
(en)
*
|
2007-04-03 |
2012-11-28 |
Oxyrane UK Limited |
Glycosylation of molecules
|
|
EP2137655B1
(en)
|
2007-04-16 |
2012-07-11 |
Momenta Pharmaceuticals, Inc. |
Defined glycoprotein products and related methods
|
|
TW200902708A
(en)
*
|
2007-04-23 |
2009-01-16 |
Wyeth Corp |
Methods of protein production using anti-senescence compounds
|
|
WO2008135498A2
(en)
|
2007-05-04 |
2008-11-13 |
Novo Nordisk A/S |
Prevention of protein degradation in mammalian cell cultures
|
|
EP1988101A1
(en)
|
2007-05-04 |
2008-11-05 |
Novo Nordisk A/S |
Improvement of factor VIII polypeptide titers in cell cultures
|
|
ES2392701T3
(es)
|
2007-05-11 |
2012-12-13 |
Amgen Inc. |
Medios de alimentación mejorados
|
|
US20100221823A1
(en)
*
|
2007-06-11 |
2010-09-02 |
Amgen Inc. |
Method for culturing mammalian cells to improve recombinant protein production
|
|
FI3597659T3
(fi)
*
|
2007-07-09 |
2023-05-03 |
Genentech Inc |
Disulfidisidoksen pelkistymisen estäminen polypeptidien rekombinantin valmistuksen aikana
|
|
EP2188371B1
(en)
|
2007-08-09 |
2017-12-20 |
Wyeth LLC |
Use of perfusion to enhance production of fed-batch cell culture in bioreactors
|
|
WO2009058769A1
(en)
|
2007-10-30 |
2009-05-07 |
Schering Corporation |
Purification of antibodies containing hydrophobic variants
|
|
DK2840090T3
(en)
|
2007-10-30 |
2018-04-23 |
Genentech Inc |
Antibody purification by cation exchange chromatography
|
|
TWM332870U
(en)
*
|
2007-11-22 |
2008-05-21 |
Delta Electronics Inc |
Side-edge type backlight module
|
|
NZ585702A
(en)
*
|
2007-11-30 |
2013-08-30 |
Abbott Lab |
Protein formulations and methods of making same
|
|
DK2235197T3
(en)
|
2007-12-27 |
2017-10-09 |
Baxalta GmbH |
Methods of cell culture
|
|
EP2275431A3
(en)
*
|
2008-01-18 |
2011-05-25 |
Bio-Rad Laboratories, Inc. |
Enhanced fractionation of phosphorylated and nonphosphorylated biomolecules by apatite chromotography
|
|
WO2009114641A1
(en)
*
|
2008-03-11 |
2009-09-17 |
Genentech, Inc. |
Antibodies with enhanced adcc function
|
|
PT2271382E
(pt)
*
|
2008-04-15 |
2013-05-07 |
Grifols Therapeutics Inc |
Ultrafiltração em dois andares/diafiltração
|
|
ES2458541T5
(en)
*
|
2008-05-02 |
2025-08-04 |
Seagen Inc |
Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation
|
|
WO2010016943A2
(en)
|
2008-08-08 |
2010-02-11 |
Biogen Idec Ma Inc. |
Nutrient monitoring and feedback control for increased bioproduct production
|
|
DK3604324T3
(da)
*
|
2008-08-14 |
2024-04-08 |
Genentech Inc |
Fremgangsmåder til at fjerne en kontaminant under anvendelse af ionbytningskromatografi med forskydning af iboende proteiner
|
|
US20100081172A1
(en)
|
2008-09-26 |
2010-04-01 |
Eureka Therapeutics, Inc. |
N-Glycans and Uses Thereof
|
|
MX2011004199A
(es)
|
2008-10-20 |
2011-05-24 |
Abbott Lab |
Anticuerpos que unen a il-18 y metodos para purificar los mismos.
|
|
NZ592095A
(en)
*
|
2008-10-20 |
2013-01-25 |
Abbott Lab |
Isolation and purification of il-12 and tnf-alpha antibodies using protein a affinity chromatography
|
|
TW201028433A
(en)
|
2008-10-20 |
2010-08-01 |
Abbott Lab |
Viral inactivation during purification of antibodies
|
|
NZ592096A
(en)
|
2008-10-20 |
2013-01-25 |
Abbott Lab |
Antibodies that bind to il-12 and methods of purifying the same
|
|
CA2739568C
(en)
*
|
2008-10-31 |
2015-12-01 |
Shujun Sun |
Purification of acidic proteins using ceramic hydroxyapatite chromatography
|
|
SG172004A1
(en)
*
|
2008-12-09 |
2011-07-28 |
Hoffmann La Roche |
Method for obtaining an excipient-free antibody solution
|
|
KR20110086184A
(ko)
|
2008-12-22 |
2011-07-27 |
에프. 호프만-라 로슈 아게 |
면역글로불린 정제
|
|
EP2373676B1
(en)
|
2009-01-08 |
2017-04-19 |
GE Healthcare BioProcess R&D AB |
Separation method using single polymer phase systems
|
|
JP5728392B2
(ja)
|
2009-03-05 |
2015-06-03 |
バイオジェン アイデック エムエー インコーポレイティドＢｉｏｇｅｎ Ｉｄｅｃ Ｉｎｃ． |
免疫グロブリンの精製
|
|
CN102365368B
(zh)
*
|
2009-03-27 |
2014-07-30 |
旭化成医疗株式会社 |
高浓度单克隆抗体溶液中的病毒去除方法
|
|
WO2010120739A1
(en)
|
2009-04-13 |
2010-10-21 |
Bristol-Myers Squibb Company |
Protein purification by citrate precipitation
|
|
RU2011142230A
(ru)
*
|
2009-04-20 |
2013-05-27 |
Пфайзер Инк. |
Контроль гликозилирования белка и композиции и способы, касающиеся этого
|
|
CA2763757A1
(en)
*
|
2009-05-28 |
2010-12-02 |
Boehringer Ingelheim International Gmbh |
Method for a rational cell culturing process
|
|
EP2438185A4
(en)
*
|
2009-06-05 |
2016-10-05 |
Momenta Pharmaceuticals Inc |
METHODS FOR MODULATING FUCOSYLATION OF GLYCOPROTEINS
|
|
MX382080B
(es)
|
2009-07-06 |
2025-03-13 |
Genentech Inc |
Método para cultivar células eucariónticas.
|
|
CN102471377B
(zh)
|
2009-07-24 |
2015-04-22 |
霍夫曼-拉罗奇有限公司 |
优化抗体的生产
|
|
WO2011015926A1
(en)
|
2009-08-03 |
2011-02-10 |
Avesthagen Limited |
A process of fermentation, purification and production of recombinant soluble tumour necrosis factor alfa receptor (tnfr) - human igg fc fusion protein
|
|
LT2462158T
(lt)
|
2009-08-06 |
2018-03-26 |
F. Hoffmann-La Roche Ag |
Viruso pašalinimo pagerinimo būdas, atliekant baltymų gryninimą
|
|
WO2011019622A1
(en)
*
|
2009-08-14 |
2011-02-17 |
Genentech, Inc. |
Cell culture methods to make antibodies with enhanced adcc function
|
|
WO2011024025A1
(en)
|
2009-08-28 |
2011-03-03 |
Avesthagen Limited |
An erythropoietin analogue and a method thereof
|
|
CA2772653C
(en)
|
2009-09-01 |
2019-06-25 |
Genentech, Inc. |
Enhanced protein purification through a modified protein a elution
|
|
US9540426B2
(en)
|
2009-10-06 |
2017-01-10 |
Bristol-Myers Squibb Company |
Mammalian cell culture processes for protein production
|
|
WO2011049798A1
(en)
*
|
2009-10-20 |
2011-04-28 |
Merck Sharp & Dohme Corp. |
Use of mixed mode chromatography for the capture and purification of basic antibody products
|
|
EP3037104B1
(en)
*
|
2009-10-20 |
2020-05-27 |
AbbVie Inc. |
Isolation and purification of anti-il-13 antibodies using protein a affinity chromatography
|
|
US9096879B2
(en)
|
2009-11-24 |
2015-08-04 |
Biogen Ma Inc. |
Method of supplementing culture media to prevent undesirable amino acid substitutions
|
|
EP2507627A2
(en)
|
2009-12-04 |
2012-10-10 |
Momenta Pharmaceuticals, Inc. |
Antennary fucosylation in glycoproteins from cho cells
|
|
US8277649B2
(en)
|
2009-12-14 |
2012-10-02 |
General Electric Company |
Membranes and associated methods for purification of antibodies
|
|
AU2010332778B2
(en)
*
|
2009-12-18 |
2015-03-19 |
Novartis Ag |
Wash solution and method for affinity chromatography
|
|
KR101405463B1
(ko)
*
|
2010-01-15 |
2014-06-27 |
그래핀스퀘어 주식회사 |
기체 및 수분 차단용 그래핀 보호막, 이의 형성 방법 및 그의 용도
|
|
JP2013523155A
(ja)
*
|
2010-04-06 |
2013-06-17 |
ヘリアエ デベロップメント、 エルエルシー |
減少する極性の溶媒を用いることによる油性原料からの油およびタンパク質性材料の順次溶媒抽出
|
|
WO2011127322A1
(en)
|
2010-04-07 |
2011-10-13 |
Momenta Pharmaceuticals, Inc. |
High mannose glycans
|
|
MX2012012526A
(es)
|
2010-04-26 |
2012-11-23 |
Novartis Ag |
Medio de cultivo celular mejorado.
|
|
JP5980772B2
(ja)
|
2010-04-26 |
2016-08-31 |
ノバルティス アーゲー |
改良型細胞培養培地
|
|
MX343604B
(es)
|
2010-05-28 |
2016-11-11 |
Genentech Inc |
Disminuir nivel de lactato e incrementar producción de polipéptidos por regulación a la baja de la expresión de lactato dehidrogenasa y piruvato dehidrogenasa quinasa.
|
|
US9012178B2
(en)
|
2010-08-05 |
2015-04-21 |
Amgen Inc. |
Dipeptides to enhance yield and viability from cell cultures
|
|
WO2012030512A1
(en)
|
2010-09-03 |
2012-03-08 |
Percivia Llc. |
Flow-through protein purification process
|
|
CN103201003B
(zh)
*
|
2010-09-20 |
2016-04-13 |
Abbvie公司 |
采用模拟移动床色谱纯化抗体
|
|
SG189872A1
(en)
*
|
2010-10-11 |
2013-06-28 |
Abbvie Inc |
Processes for purification of proteins
|
|
JP5918697B2
(ja)
|
2010-10-15 |
2016-05-18 |
Ｊｃｒファーマ株式会社 |
糖鎖の非還元末端がマンノース残基である糖蛋白質の製造方法
|
|
EP2450375A1
(en)
|
2010-11-09 |
2012-05-09 |
Sandoz Gmbh |
Cell culture medium and process for protein expression, said medium and process comprising a PAM inhibitor
|
|
CN103429609A
(zh)
*
|
2010-12-08 |
2013-12-04 |
安姆根有限公司 |
在氨基酸存在下的离子交换层析
|
|
US20140162317A1
(en)
|
2010-12-21 |
2014-06-12 |
Roberto Falkenstein |
Isoform entriched antibody preparation and method for obtaining it
|
|
WO2012120500A2
(en)
|
2011-03-06 |
2012-09-13 |
Merck Serono S.A. |
Low fucose cell lines and uses thereof
|
|
PL2697369T3
(pl)
|
2011-03-25 |
2018-12-31 |
F.Hoffmann-La Roche Ag |
Nowe sposoby oczyszczania białek
|
|
EP2511293A1
(en)
|
2011-04-13 |
2012-10-17 |
LEK Pharmaceuticals d.d. |
A method for controlling the main complex N-glycan structures and the acidic variants and variability in bioprocesses producing recombinant proteins
|
|
US9133493B2
(en)
|
2011-04-21 |
2015-09-15 |
Amgen Inc. |
Method for culturing mammalian cells to improve recombinant protein production
|
|
CN105189735B
(zh)
|
2011-04-29 |
2019-04-12 |
拜康研究有限公司 |
在培养期间减少乳酸累积的方法和生产多肽的方法
|
|
US20120283419A1
(en)
|
2011-05-03 |
2012-11-08 |
Avantor Performance Materials, Inc. |
Separation of protein monomers from aggregates by solid weak anion exchange support functionalized with amine moieties
|
|
US9562252B2
(en)
|
2011-05-13 |
2017-02-07 |
Biogen Ma Inc. |
Methods of preventing and removing trisulfide bonds
|
|
IL315908A
(en)
|
2011-07-01 |
2024-11-01 |
Amgen Inc |
Mammalian cell culture
|
|
WO2013006461A1
(en)
|
2011-07-01 |
2013-01-10 |
Biogen Idec Ma Inc. |
Cholesterol-based media supplementals for cell culture
|
|
US9475858B2
(en)
|
2011-07-08 |
2016-10-25 |
Momenta Pharmaceuticals, Inc. |
Cell culture process
|
|
WO2013013013A2
(en)
|
2011-07-21 |
2013-01-24 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for producing modified glycoproteins
|
|
JP6356605B2
(ja)
|
2011-10-19 |
2018-07-11 |
ロシュ グリクアート アーゲー |
フコシル化抗体の分離法
|
|
US9150645B2
(en)
*
|
2012-04-20 |
2015-10-06 |
Abbvie, Inc. |
Cell culture methods to reduce acidic species
|
|
US9249182B2
(en)
*
|
2012-05-24 |
2016-02-02 |
Abbvie, Inc. |
Purification of antibodies using hydrophobic interaction chromatography
|
|
US9085618B2
(en)
*
|
2013-10-18 |
2015-07-21 |
Abbvie, Inc. |
Low acidic species compositions and methods for producing and using the same
|